Stockscreener 앱 받기
381.36
0.83%
3.14
시간 외 거래:
381.36
전일 마감가:
$378.22
열려 있는:
$377.85
하루 거래량:
1.62M
Relative Volume:
1.03
시가총액:
$139.34B
수익:
$23.22B
순이익/손실:
$2.86B
주가수익비율:
51.54
EPS:
7.4
순현금흐름:
$3.58B
1주 성능:
+4.06%
1개월 성능:
+10.28%
6개월 성능:
+3.11%
1년 성능:
+16.11%
1일 변동 폭
$373.06
$383.99
1주일 범위
$363.08
$383.99
52주 변동 폭
$314.93
$406.19
스트라이커 Stock (SYK) Company Profile
명칭
Stryker Corp
전화
(269) 389-2600
주소
2825 AIRVIEW BLVD, KALAMAZOO, MI
SYK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
381.36 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
ABT
Abbott Laboratories
|
132.60 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.24 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
MDT
Medtronic Plc
|
83.45 | 107.01B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.11 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
스트라이커 Stock (SYK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-26 | 재개 | Citigroup | Buy |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-10 | 개시 | Wolfe Research | Outperform |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-22 | 업그레이드 | Needham | Hold → Buy |
| 2024-01-31 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2023-10-20 | 개시 | ROTH MKM | Buy |
| 2023-09-05 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-01-25 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2023-01-09 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-11-01 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-28 | 업그레이드 | Edward Jones | Hold → Buy |
| 2022-07-21 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-07-11 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-04-13 | 개시 | Truist | Hold |
| 2022-03-16 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2022-03-15 | 재개 | Evercore ISI | Outperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-12-10 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-12-07 | 개시 | Loop Capital | Buy |
| 2021-09-14 | 재개 | Raymond James | Mkt Perform |
| 2021-07-28 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2021-06-01 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2021-05-25 | 개시 | Barclays | Underweight |
| 2020-10-06 | 개시 | Northland Capital | Market Perform |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-04-13 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2020-04-01 | 다운그레이드 | Goldman | Buy → Sell |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-08 | 개시 | SunTrust | Hold |
| 2020-01-07 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2019-12-30 | 재확인 | BTIG Research | Buy |
| 2019-11-05 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-10-30 | 재확인 | BofA/Merrill | Buy |
| 2019-07-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-01-30 | 재확인 | Canaccord Genuity | Buy |
| 2019-01-03 | 개시 | Deutsche Bank | Buy |
| 2019-01-02 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-08-16 | 개시 | BTIG Research | Buy |
| 2018-06-27 | 개시 | Bernstein | Mkt Perform |
| 2018-04-27 | 재확인 | Stifel | Buy |
모두보기
스트라이커 주식(SYK)의 최신 뉴스
Stryker (SYK) Price Target Raised by Truist Securities | SYK Stock News - GuruFocus
UBS lifts Stryker stock price target to $421 from $405 - Investing.com
Demystifying Stryker: Insights From 5 Analyst Reviews - Benzinga
Stryker's (SYK) Price Target Raised by Truist Amid Strong Growth | SYK Stock News - GuruFocus
Stryker (SYK) Receives Price Target Boost Following Strong Quarterly Results | SYK Stock News - GuruFocus
Decoding Stryker Corp (SYK): A Strategic SWOT Insight - GuruFocus
Stryker Corp’s Earnings Call Highlights Robust Growth - TipRanks
Stryker price target raised to $456 from $405 at Roth Capital - TipRanks
Stryker says bribery probe dropped by US Justice Department - MLex
Stryker (SYK) Lands a Higher Price Target from Roth MKM | SYK Stock News - GuruFocus
Stryker (SYK) Rating Maintained, Price Target Lowered by Evercore ISI Group | SYK Stock News - GuruFocus
Medical Equipment Makers Stryker, Becton Eye Price Hikes to Offset Tariffs - Bloomberg
Stryker (SYK): Roth Capital Boosts Price Target Amid Strong Q1 P - GuruFocus
Stryker raises forecast on strong sales despite $200M tariff hit - Crain's Grand Rapids Business
Stryker Corporation (SYK) Sees Strong Q1 2025 Growth Amid Strate - GuruFocus
Stryker Corporation (NYSE:SYK) Q1 2025 Earnings Call Transcript - Insider Monkey
Stryker stock target cut to $390 by Evercore ISI - Investing.com
Stryker beats quarterly estimates of string medical device demand - Reuters
Stryker Corp Reports Strong Q1 2024 Earnings Growth - TipRanks
Stryker Corp (SYK) Q1 2025 Earnings Call Highlights: Strong Organic Growth and Strategic ... - Yahoo Finance
Stryker Corp (SYK) Q1 2025 Earnings: Revenue Surpasses Estimates at $5.9 Billion, EPS Falls Short at $1.69 - GuruFocus
Stryker Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Stryker: Q1 Earnings Snapshot - MySA
Stryker Corporation (SYK) Sees Strong Q1 2025 Growth Amid Strategic Shifts - GuruFocus
Stryker's Profits Outshine Forecasts Thanks To Device Demand - Finimize
Earnings call transcript: Stryker Q1 2025 beats EPS forecasts, stock dips By Investing.com - Investing.com South Africa
Earnings call transcript: Stryker Q1 2025 beats EPS forecasts, stock dips - Investing.com
Stryker reports first quarter 2025 operating results - ADVFN
Stryker (SYK) Surpasses Q1 Earnings and Revenue Estimates - Yahoo
Stryker earnings beat by $0.13, revenue topped estimates - Investing.com
Stryker beats Q1 estimates, raises 2025 organic sales outlook By Investing.com - Investing.com India
Stryker beats Q1 estimates, raises 2025 organic sales outlook - Investing.com
Stryker Corp. Q1 Profit Decreases, But Beats Estimates - Nasdaq
Here's How Much $1000 Invested In Stryker 10 Years Ago Would Be Worth Today - Benzinga
Global Spinal Stenosis Devices Market to reach USD 4,131.08 million at a CAGR of 4.83% by 2030, Evaluates DelveInsight | Spinal Simplicity, Boston Scientific Corporation, Medtronic, Stryker, Surgalig - Barchart.com
Stryker (SYK) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Stryker Leadership Team Set to Share Strategic Insights at Major Healthcare Conference - Stock Titan
Stryker Corporation (SYK): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential - Insider Monkey
Stryker (SYK) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Stryker Corp (SYK) Stock Price Up 3.26% on Apr 23 - GuruFocus
Paul Harris' Past Picks: Stryker, Essilor Luxottica & Novo Nordisk - BNN Bloomberg
TD Cowen maintains Stryker stock Buy rating, $435 target - Investing.com
TD Cowen maintains Stryker stock Buy rating, $435 target By Investing.com - Investing.com UK
Stryker accuses German rival Fiagon of patent infringement at USITC - MLex
Stryker Corporation (SYK): A Bull Case Theory - MSN
William Schamel Stryker - San Diego Union-Tribune
Here's What to Expect From Stryker Corporation's Next Earnings Report - Nasdaq
Here's What To Expect From Stryker Corporation's Next Earnings Report - Barchart.com
Fed. Circ. Won't Revive Stryker Unit's Antiseptic Patents - Law360
Federal Circuit Axes Stryker Unit’s Sterilized Wipe Patents - Bloomberg Law News
The Zacks Analyst Blog Bank of America, Chevron, Stryker, Value Line and Sypris - Yahoo Finance
스트라이커 (SYK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.66%
자본화:
|
볼륨(24시간):